Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SERATEK
- Development stage
- Unknown
- Lead developer
- Emplicure
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
SERATEK is a patented bioceramic technology developed by Emplicure, designed to enhance and accelerate nicotine delivery in oral nicotine pouches. It consists of a precision-engineered calcium compound coated in nicotine and blended with food-grade ingredients. The technology is intended for tobacco harm reduction by providing a faster nicotine release profile compared to traditional pouches, with pharmacokinetic studies showing 80% nicotine delivery within the first five minutes. It is licensed to global nicotine pouch producers and is the core technology in the KLAR product line.
- Brand names
- SERATEKKLAR
- Other names
- bioceramic technology
02
Targets
Nicotinic Acetylcholine Receptor
Beyond the preview
Go deeper on SERATEK.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SERATEK.